Can ICER Put a Price on Asthma Control?

October 17, 2018

The Institute for Clinical and Economic Review says new medicine for uncontrolled asthma isn’t worth its cost. But its analysis omits key details.

View the Graphic.

View Social Graphics.

Categorized in: Analysis

◀ Next Post

Previous Post ►